Need a prescription for Libre systems?
Make in-the-moment food choices.
With Libre Assist*, one photo helps you see your food’s potential glucose impact‡. Just like that!
Try Libre Assist*—a feature only in the Libre app†.
The FreeStyle Libre 3 Plus sensor, along with Libre Assist*, can help you predict the impact of food on your glucose‡.
Plus, your first sensor may be free♢! No credit card required, no strings attached.
-
Snap.
Take a photo of your food.
-
Predict.
Libre Assist* predicts how your food can impact glucose‡.
-
Know.
Get personalized food suggestions§ to help lower glucose impact.
See how it works.
Learn more with these how-to videos.
How to use Libre Assist* in the Libre app†
How to add food to Libre Assist* in the Libre app†
See patterns and trends that show the impact of every meal, every workout, and every dose||.
Ask your doctor for a FreeStyle Libre 3 Plus sensor prescription today.
With minute-to-minute readings, you can manage your diabetes with confidence¶1 and lower your A1C¶2.
It’s painless to apply3.
The small 15-day sensor is painless to apply and comfortable to wear3.
It’s convenient.
Without fingersticks#, you have less to manage and worry about. Glucose readings are sent to your smartphone†.
It's easy to use¶4.
You can monitor glucose discreetly, comfortably3, and conveniently anytime|| and anywhere**, just by checking your smartphone†.
Learn More about CGMs Here.
CGM= Continuous Glucose Monitoring
Download the latest version of the Libre app† now to use Libre Assist*.
More people pay $0–$20 for Libre than for Dexcom††5.
The FreeStyle Libre 3 system includes the Libre 3 Plus sensor, Libre 3 sensor, Libre 3 app, Libre app, and the Libre 3 reader.
The FreeStyle Libre 2 system includes the Libre 2 Plus sensor, Libre 2 sensor, Libre app, and the Libre 2 reader.
The product images are for illustrative purposes only. Not actual patient data.
Medicare and other payor criteria may apply. Abbott provides this information as a courtesy and does not guarantee payment or coverage.
Coverage and out-of-pocket costs may vary based on your individual insurance plan. Please contact your insurance provider directly to confirm your specific benefits and eligibility.
* Libre Assist is a feature within Libre app that uses generative artificial intelligence to provide information on how foods could impact your glucose levels. Generative artificial intelligence may not always be accurate, and it should not be used to make treatment decisions.
† The FreeStyle Libre systems apps are only compatible with certain mobile devices and operating systems. Please check the Support section of our website for more information about device compatibility before using the apps. Use of the FreeStyle Libre systems apps may require registration with LibreView.
‡ Predicted glucose impact is based on user-provided food data and may differ from actual impact, which depends on sensor readings and factors like activity, stress, medication, and alcohol. For personalized advice, consult your healthcare provider.
§ Personalized food suggestions are based on food preference information inputted by the user.
|| 60-minute warm-up required when starting the sensor.
¶ Study was performed with the outside US version of the FreeStyle Libre 14 day system. Data is applicable to FreeStyle Libre 2 and FreeStyle Libre 3 systems, as feature sets are similar as FreeStyle Libre 14 day system, excluding alarms.
# Fingersticks are required if your glucose alarms and readings do not match symptoms or when you see Check Blood Glucose symbol during the first twelve hours.
** Sensor is water-resistant in up to 1 meter (3 feet) of water. Do not immerse longer than 30 minutes.
†† Based on pharmacy claims for the aggregate of patients covered by Commercial insurance, Managed Medicare, Managed Medicaid using the FreeStyle Libre personal CGM systems versus Dexcom CGM systems. Does not include fee-for-service Medicare or fee-for-service Medicaid. The actual cost to patients may or may not be lower than other CGM systems, depending on the amount covered by insurance, if any.
‡‡ Based on prescription claims for commercially insured and uninsured patients using the FreeStyle Libre personal CGM systems. May not include Medicare, Medicaid, and other federal or state healthcare program patients. The actual amount a patient pays may vary. FreeStyle Libre personal CGM systems require a prescription.
§§ Benefits apply to FreeStyle Libre personal CGM sensors and readers. Void where prohibited by law. Abbott may modify, rescind, or revoke these benefits at any time without notice. Offer available to commercially insured and uninsured patients only. These benefits are not available to beneficiaries of Medicare, Medicaid or other federal or state healthcare programs. For Massachusetts residents, only those patients responsible for the full cost of the product may be eligible to receive these benefits. These benefits are only available at participating pharmacies, which are subject to change without notice. The actual amount a patient pays may vary.
References: 1. Fokkert, Marion, et al. “Improved Well-Being and Decreased Disease Burden After 1-Year Use of Flash Glucose Monitoring (FLARE-NL4).” BMJ Open Diabetes Research and Care 7, no. 1 (2019): e000809. https://doi.org/10.1136/bmjdrc-2019-000809. 2. Evans, Mark, Zoë Welsh, Sara Ells, and Alexander Seibold. “The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: a Meta-analysis of Clinical Trials and Real-World Observational Studies.” Diabetes Therapy 11, no. 1 (2020): 83–95. https://doi.org/10.1007/s13300-019-00720-0. 3. Alva, Shridhara, et al. “Accuracy of a 15-Day Factory-Calibrated Continuous Glucose Monitoring System With Improved Sensor Design.” Journal of Diabetes Science and Technology (2025): 19322968251329364. https://doi.org/10.1177/19322968251329364. 4. Haak, Thomas, et al. “Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: A Multicenter, Open-Label Randomized Controlled Trial.” Diabetes Therapy 8, no. 1 (2017): 55–73. https://doi.org/10.1007/s13300-016-0223-6. 5. Data on file. Abbott Diabetes Care, Inc.
ADC-2689665 v2.0